Literature DB >> 16606933

Lariat branch point mutation in the dysferlin gene with mild limb-girdle muscular dystrophy.

Michael Sinnreich1, Christian Therrien, George Karpati.   

Abstract

The authors report a genotype-phenotype correlation in a limb-girdle muscular dystrophy 2B family. Two severely affected sisters were homozygous for a dysferlin null mutation. Their mildly affected compound heterozygous mother harbored, in addition to one null allele, an in-frame exon-skipping allele caused by a novel lariat branch point mutation. The dysferlin molecule arising from the latter allele appeared to partially complement the null mutation, likely accounting for the mother's mild phenotype.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16606933     DOI: 10.1212/01.wnl.0000204358.89303.81

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  15 in total

1.  Therapeutic exon 'switching' for dysferlinopathies?

Authors:  Nicolas Lévy; Nicolas Wein; Florian Barthelemy; Vincent Mouly; Luis Garcia; Martin Krahn; Marc Bartoli
Journal:  Eur J Hum Genet       Date:  2010-05-26       Impact factor: 4.246

2.  Proteasomal inhibition restores biological function of mis-sense mutated dysferlin in patient-derived muscle cells.

Authors:  Bilal A Azakir; Sabrina Di Fulvio; Jochen Kinter; Michael Sinnreich
Journal:  J Biol Chem       Date:  2012-02-08       Impact factor: 5.157

3.  Modular dispensability of dysferlin C2 domains reveals rational design for mini-dysferlin molecules.

Authors:  Bilal A Azakir; Sabrina Di Fulvio; Steven Salomon; Marielle Brockhoff; Christian Therrien; Michael Sinnreich
Journal:  J Biol Chem       Date:  2012-06-26       Impact factor: 5.157

Review 4.  Translational research and therapeutic perspectives in dysferlinopathies.

Authors:  Florian Barthélémy; Nicolas Wein; Martin Krahn; Nicolas Lévy; Marc Bartoli
Journal:  Mol Med       Date:  2011-05-06       Impact factor: 6.354

5.  XPC branch-point sequence mutations disrupt U2 snRNP binding, resulting in abnormal pre-mRNA splicing in xeroderma pigmentosum patients.

Authors:  Sikandar G Khan; Koji Yamanegi; Zhi-Ming Zheng; Jennifer Boyle; Kyoko Imoto; Kyu-Seon Oh; Carl C Baker; Engin Gozukara; Ahmet Metin; Kenneth H Kraemer
Journal:  Hum Mutat       Date:  2010-02       Impact factor: 4.878

6.  Therapeutic exon skipping for dysferlinopathies?

Authors:  Annemieke Aartsma-Rus; Kavita H K Singh; Ivo F A C Fokkema; Ieke B Ginjaar; Gert-Jan van Ommen; Johan T den Dunnen; Silvère M van der Maarel
Journal:  Eur J Hum Genet       Date:  2010-02-10       Impact factor: 4.246

7.  Otoferlin acts as a Ca2+ sensor for vesicle fusion and vesicle pool replenishment at auditory hair cell ribbon synapses.

Authors:  Didier Dulon; Saaid Safieddine; Christine Petit; Nicolas Michalski; Juan D Goutman; Sarah Marie Auclair; Jacques Boutet de Monvel; Margot Tertrais; Alice Emptoz; Alexandre Parrin; Sylvie Nouaille; Marc Guillon; Martin Sachse; Danica Ciric; Amel Bahloul; Jean-Pierre Hardelin; Roger Bryan Sutton; Paul Avan; Shyam S Krishnakumar; James E Rothman
Journal:  Elife       Date:  2017-11-07       Impact factor: 8.140

8.  Human Splicing Finder: an online bioinformatics tool to predict splicing signals.

Authors:  François-Olivier Desmet; Dalil Hamroun; Marine Lalande; Gwenaëlle Collod-Béroud; Mireille Claustres; Christophe Béroud
Journal:  Nucleic Acids Res       Date:  2009-04-01       Impact factor: 16.971

Review 9.  Limb-girdle muscular dystrophies: where next after six decades from the first proposal (Review).

Authors:  Omar A Mahmood; Xin Mei Jiang
Journal:  Mol Med Rep       Date:  2014-03-13       Impact factor: 2.952

10.  A novel dysferlin mutant pseudoexon bypassed with antisense oligonucleotides.

Authors:  Janice A Dominov; Ozgün Uyan; Peter C Sapp; Diane McKenna-Yasek; Babi R R Nallamilli; Madhuri Hegde; Robert H Brown
Journal:  Ann Clin Transl Neurol       Date:  2014-09-27       Impact factor: 4.511

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.